# Effect of Triple Combination of Induction, Concurrent and Adjuvant Chemotherapy in High Risk Nasopharyngeal Carcinoma

> **NCT02621970** · PHASE3 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 534 (estimated)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **DRUG:** Cisplatin 1
- **DRUG:** Cisplatin 2
- **DRUG:** Docetaxel
- **DRUG:** Xeloda
- **RADIATION:** Intensity-modulated radiotherapy

## Key facts

- **NCT ID:** NCT02621970
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01
- **Primary completion:** 2022-01
- **Final completion:** 2024-01
- **Target enrollment:** 534 (ESTIMATED)
- **Last updated:** 2015-12-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02621970

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02621970, "Effect of Triple Combination of Induction, Concurrent and Adjuvant Chemotherapy in High Risk Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02621970. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*